Frontier Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,444
Closed -$275K 414
2018
Q3
$275K Sell
1,444
-832
-37% -$153K 0.03% 317
2018
Q2
$379K Sell
2,276
-617
-21% -$99.1K 0.05% 253
2018
Q1
$487K Sell
2,893
-269
-9% -$45.1K 0.07% 231
2017
Q4
$517K Buy
3,162
+463
+17% +$83.1K 0.08% 206
2017
Q3
$553K Buy
2,699
+1,315
+95% +$306K 0.08% 215
2017
Q2
$336K Buy
+1,384
New +$325K 0.05% 276
2016
Q1
Sell
-664
Closed -$208K 375
2015
Q4
$208K Sell
664
-200
-23% -$59.5K 0.03% 313
2015
Q3
$235K Sell
864
-13
-1% -$3.99K 0.04% 284
2015
Q2
$266K Buy
+877
New +$262K 0.04% 272

Other funds holding AGN

Frontier Wealth Management's AGN Position: Q4 2018 in Review

Frontier Wealth Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,444 shares — an estimated $275K sold.

Frontier Wealth Management first reported a position in AGN in Q2 2015 and held it in 9 quarters. The position peaked at $553K in Q3 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Frontier Wealth Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Frontier Wealth Management sold 1,444 Allergan plc shares in Q4 2018, an estimated $275K.
  • Frontier Wealth Management first reported a position in Allergan plc in Q2 2015 and held it in 9 quarters.
  • Frontier Wealth Management's Allergan plc position peaked at $553K in Q3 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Frontier Wealth Management's 13F filing for Q4 2018, filed 14 Feb 2019.